Form 4: Recursion Pharmaceuticals CFO Adjusts Holdings

Recursion Pharmaceuticals, Inc. reports a transaction by its Chief Financial Officer, Ben R. Taylor, involving Class A Common Stock.

Summary

• Ben R. Taylor, Chief Financial Officer of Recursion Pharmaceuticals, Inc. (RXRX), reported a transaction on April 6, 2026.
• The transaction involved the withholding of shares by the Issuer to cover tax obligations related to the net settlement of restricted stock units.
• A total of 48,028 shares were involved in this transaction, with a price of $3.11 per share.
• Following this transaction, Mr. Taylor beneficially owns 1,132,290 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a standard tax-related transaction by an executive rather than a strategic investment or divestment.

Positives

• The Chief Financial Officer continues to hold a significant number of shares (1,132,290) in the company, indicating continued confidence.
• The transaction is related to tax withholding for restricted stock units, a common and expected event in executive compensation.

Negatives

• The filing indicates a disposition of 48,028 shares, which, while for tax purposes, represents a reduction in the CFO's direct holdings.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and are crucial for understanding executive confidence and potential shifts in beneficial ownership within the biotechnology and pharmaceutical sector.

Stakeholder Impact

• Shareholders: The filing provides transparency into executive holdings, which can influence investor perception of management's commitment.
• Employees: Indirectly relevant as it pertains to executive compensation and stock-based awards.

Key Dates

Keywords

Form 4, SEC Filing, Recursion Pharmaceuticals, RXRX, Ben R. Taylor, Chief Financial Officer, Class A Common Stock, Beneficial Ownership, Restricted Stock Units, Tax Withholding